PuraPharm Corporation Limited Profile Avatar - Palmy Investing

PuraPharm Corporation Limited

PuraPharm Corporation Limited, an investment holding company, researches, develops, produces, and sells concentrated Chinese medicine granule (CCMG) and Chinese healthcare products in Hong Kong, Mainland China, and internationally. It operates through fi…

Drug Manufacturers - Specialty & Generic
HK, Tai Po [HQ]
Strategy & Leadership

Mergers & Acquisitions Beta

M&A Deals · Breakdown

PuraPharm Corporation Limited has no acquisition track records yet.

M&A Deals · History

PuraPharm Corporation Limited has no acquisition track records yet.

M&A Deals · Within Industry

No current deals within Drug Manufacturers - Specialty & Generic Industry.

M&A Deals · Latest

Act, dont react; Track the most urgent M&A deals across all industries

Details
Owens Corning
Debt
Agg. Maximum Price
$373,155,000.00
Details
?
Equity
Agg. Maximum Price
$n/a
Details
?
Equity
Agg. Maximum Price
$4,221.65
?
Details
?
Equity
Agg. Maximum Price
$2,264,484.00
Details
United Bankshares, Inc.
Equity
Agg. Maximum Price
$206,633,909.86
?
Details
?
Equity
Agg. Maximum Price
$381.73
Details
?
Equity
Agg. Maximum Price
$7,657,428.54
Details
Icahn Enterprises L.P.
Debt
Agg. Maximum Price
$700,000,000.00
?
Details
?
Equity
Agg. Maximum Price
$19,377,844.50
Details
Corebridge Financial, Inc.
Debt
Agg. Maximum Price
$500,000,000.00
End of 1498.HK's Analysis
CIK: - CUSIP: G7306Y104 ISIN: KYG7306Y1044 LEI: - UEI: -
Secondary Listings
1498.HK has no secondary listings inside our databases.